TABLE 3

Asthma remission: future research questions

Definition
1Does the definition of remission require measurement of inflammation?
2How do asthma control and severity relate to asthma remission?
Treatment-induced remission
3Is treatment-induced remission possible?
4How does treatment-induced remission compare with spontaneous asthma remission, based on prevalence, predictors and risk of relapse?
5Is it possible to increase the proportion of people achieving remission with treatment?
6Is it possible to prolong the remission period with treatment?
7What are the rates of remission with MART and step therapy?
8Does prolonging asthma treatment after control is achieved increase the chance of asthma remission?
Trajectory of remission
9How long should the treatment be continued to achieve remission? When to move from one stage to another?
Pathophysiology
10What are the molecular events leading to airway remodelling?
11Can airway remodelling be treated?
12Does treating airway remodelling induce remission?
Relapse
13How does ongoing airway inflammation and remodelling affect relapse?
14How can inflammation/remodelling be effectively treated to prevent relapse in those who are in clinical remission?
Biologics and asthma remission
15What is the prevalence of remission after biologics therapy for asthma?
16Are biologics more effective than inhaled preventers at achieving asthma remission?
17Does the early introduction of biologics modify the trajectory of asthma and halt the disease progression?
18Does continuing the treatment with biologics prolong remission and prevent relapse?
19Is it possible to stop all asthma treatments except biologics in a patient who has achieved remission with biological therapies?
Macrolide therapy
20What is the prevalence of remission after macrolide therapy for asthma?
Treatable traits
21Does targeting treatable traits increase the chance of asthma remission?

MART: maintenance and reliever therapy.